.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Argus Health
Express Scripts
US Department of Justice
Fish and Richardson
Daiichi Sankyo
Cerilliant
Cantor Fitzgerald
Deloitte
Merck

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Paramagnetic metal-diethylenetriamine-pentaacetic acid partial amide complexes for magnetic resonance imaging
Abstract:Complexes of a highly paramagnetic polyvalent metal, e.g., a lanthanide such as gadolinium, or of a less paramagnetic metal, e.g., iron, manganese, copper, cobalt, chromium or nickel, with a bisalkylamide of diethylenetriaminepentaacetic acid of the formula: ##STR1## wherein three groups M are hydroxyl groups and the remaining two groups M are NHR groups in which each group R is an alkyl group of the formula --(CH.sub.2).sub.n CH.sub.3 where n is zero or an integer of from 1 to 17, are disclosed. These complexes are useful as magnetic resonance imaging contrast enhancers.
Inventor(s): Quay; Steven C. (Palo Alto, CA)
Assignee: Salutar, Inc. (Sunnyvale, CA)
Filing Date:Jul 31, 1989
Application Number:07/386,806
Claims:1. In a process of NMR imaging of a subject comprising administering to said subject a composition containing an image-modifying effective amount of an image enhancer, permitting the enhancer to move through the subject, and after a time interval taking an NMR image of the subject, the improvement which comprises administering as said enhancer a complex of a paramagnetic polyvalent metal and a partial amide of diethylenetriaminepentaacetic acid of formula I ##STR4## in which three groups M are hydroxyl groups and the remaining two groups M are NHR groups, where each group R is an alkyl group of formula --(CH.sub.2).sub.n CH.sub.3 where n is zero or an integer of from 1 to 17.

2. A process according to claim 1, wherein there is administered a said complex wherein the paramagnetic metal is selected from the group consisting of iron, manganese, copper, cobalt, chromium and nickel.

3. A process according to claim 1, wherein there is administered a said complex wherein the paramagnetic metal is iron.

4. A process according to claim 1, wherein there is administered a said complex wherein the paramagnetic metal is selected from the group consisting of gadolinium, lanthanum, cerium, praseodymium, neodymium, promethium, samarium, europium, terbium, dysprosium, holmium, erbium, thulium, ytterbium and lutetium.

5. A process according to claim 1, wherein there is administered a said complex wherein the paramagnetic metal is gadolinium.

6. A process according to claim 1, wherein said complex is administered orally or parenterally at a dosage of 1 to 100 .mu.mol complex/kg bodyweight.

7. A process according to claim 2 wherein said complex is administered orally or parenterally at a dosage of 1 to 100 .mu.mol complex/kg bodyweight.

8. A process according to claim 3 wherein said complex is administered orally or parenterally at a dosage of 1 to 100 .mu.mol complex/kg bodyweight.

9. A process according to claim 4 wherein said complex is administered orally or parenterally at a dosage of 1 to 100 .mu.mol complex/kg bodyweight.

10. A process according to claim 5 wherein said complex is administered orally or parenterally at a dosage of 1 to 100 .mu.mol complex/kg bodyweight.

11. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(methylcarbamoylmethyl)-3,6,9-triazundecanedioic acid.

12. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(ethylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

13. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(propylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

14. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(butylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

15. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(pentylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

16. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(hexylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

17. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-j,9-bis(heptylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

18. A process according to claim 11 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(octylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

19. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(nonylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

20. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(decylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid.

21. A process according to claim 1 comprising administering as said complex a complex of a paramagnetic metal and 6-carboxymethyl-3,9-bis(hexadecylcarbamoylmethyl)-3,6,9-triazaundecanedioi c acid.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Novartis
Chinese Patent Office
McKesson
Farmers Insurance
Chubb
Boehringer Ingelheim
Johnson and Johnson
Fuji
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot